Company: SRPT
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029973
Chunk: 280

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 1
Chunk 280
---
in Technologies BV on the other hand
     
    10-Q
     
    001-14895
     
    10.1
     
    8/7/19

     10.41†
     
    Amendment No. 1 to the Sarepta Therapeutics, Inc. Amended and Restated 2013 Employment Stock Purchase Plan (as Amended and Restated on June 27, 2016)
     
    10-Q
     
    001-14895
     
    10.4
     
    8/7/19

     10.42
     
    Letter Agreement between Sarepta Therapeutics, Inc. and Myonexus Therapeutics, Inc. dated February 26, 2019
     
    10-Q
     
    001-14895
     
    10.1
     
    5/8/19

     10.43†
     
    Form of Executive Vice President Severance Letter Agreement
     
    10-Q
     
    001-14895
     
    10.2
     
    5/8/19

     10.44†
     
    Form of Executive Vice President Change in Control and Severance Agreement 
     
    10-Q
     
    001-14895
     
    10.3
     
    5/8/19

     10.45^
     
    License, Collaboration, and Option Agreement between Sarepta Therapeutics Three, LLC and F. Hoffman-La Roche Ltd dated December 21, 2019
     
    10-K
     
     001-14895
     
    10.51
     
    2/26/20

     10.46†
     
    Director Compensation Policy
     
    10-K
     
     001-14895
     
    10.55
     
    2/26/20

     10.47†
     
    Amendment No. 2 to the Sarepta Therapeutics, Inc. 2014 Employment Commencement Incentive Plan
     
    8-K
     
    001-14895
     
    10.1
     
    2/21/20

     10.